| 1 |
23929924 | Determinants and changes associated with aldosterone breakthrough after angiotensin II receptor blockade in patients with type 2 diabetes with overt nephropathy. | 2013 Oct |
1 |
| 2 |
20860414 | The role of Angiotensin receptor blocker and calcium channel blocker combination therapy in treating hypertension: focus on recent studies. | 2010 |
1 |
| 3 |
18802434 | Aliskiren fails to lower blood pressure in patients who have either low PRA levels or whose PRA falls insufficiently or reactively rises. | 2009 Jan |
1 |
| 4 |
19791837 | The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus. | 2009 |
1 |
| 5 |
17409317 | Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. | 2007 May |
1 |
| 6 |
17699488 | Relationships of plasma renin levels with renal function in patients with primary aldosteronism. | 2007 Jul |
2 |
| 7 |
15284283 | Ischemic nephropathy: where are we now? | 2004 Aug |
1 |
| 8 |
11423564 | Use of positron emission tomography to study AT1 receptor regulation in vivo. | 2001 Jul |
1 |
| 9 |
11583143 | Pharmacology of cardiovascular chronotherapeutic agents. | 2001 Sep |
1 |
| 10 |
11053481 | Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. | 2000 Nov |
1 |
| 11 |
8021906 | Endurance exercise in mild hypertension: effects on blood pressure and associated metabolic and quality of life variables. | 1994 Apr |
1 |
| 12 |
1956022 | The causes of raised blood pressure in insulin-dependent and non-insulin-dependent diabetes. | 1991 Aug |
1 |
| 13 |
2674444 | Localisation and physiological effects of tissue renin-angiotensin systems. | 1989 Jun |
1 |
| 14 |
2977405 | Platelet-activating factor and anti-platelet-aggregating factor in acute reduction of blood pressure following percutaneous transluminal renal angioplasty in patients with renovascular hypertension. | 1988 Aug |
1 |
| 15 |
3037886 | Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical structure and biologic activity. | 1987 Jul |
2 |
| 16 |
7015795 | Captopril, an orally active converting enzyme inhibitor, in the treatment of primary hypertension. A controlled long-term study with reference to initial plasma renin activity. | 1981 |
1 |